How do I buy Kiniksa Pharmaceuticals (KNSA) stock?

You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) through any online brokerage.View our list of the best stock brokerages

Who are Kiniksa Pharmaceuticals (KNSA) competitors?

Other companies in Kiniksa Pharmaceuticals’s space includes: Immunome Inc (NASDAQ:IMNM), IDEAYA Biosciences Inc (NASDAQ:IDYA), Legend Biotech Corp (NASDAQ:LEGN), Twist Bioscience Corp (NASDAQ:TWST) and Centessa Pharmaceuticals PLC (NASDAQ:CNTA).

What is the forecast, or price target, for Kiniksa Pharmaceuticals (KNSA) stock?

Kiniksa Pharmaceuticals has a consensus price target of $48.63.

What is the current price for Kiniksa Pharmaceuticals (KNSA)?

The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $42.2 last updated January 23, 2026 at 4:00 PM EST.

Does Kiniksa Pharmaceuticals (KNSA) pay a dividend?

There are no upcoming dividends for Kiniksa Pharmaceuticals.

When is Kiniksa Pharmaceuticals (NASDAQ:KNSA) reporting earnings?

Kiniksa Pharmaceuticals does not have any upcoming earnings scheduled.

Is Kiniksa Pharmaceuticals (KNSA) going to split?

There is no upcoming split for Kiniksa Pharmaceuticals.

What sector and industry does Kiniksa Pharmaceuticals (KNSA) operate in?

Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kiniksa Pharmaceuticals (KNSA) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical...

Comments